Farther Finance Advisors »

Lyell Immunopharma shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $2 1 2.00

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard S&p 500 Etf Etf (VOO)
Nvidia Corporation Stock (NVDA)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Uva Unconstrained Medium-term Fixed Income Etf Etf (FFIU)
Apple Stock (AAPL)
Vanguard Intermediate-term Bond Etf Etf (BIV)
Microsoft Corp Stock (MSFT)
Vanguard Short-term Bond Etf Etf (BSV)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Ishares National Muni Bond Etf Etf (MUB)
Ishares Core Msci Eafe Etf Etf (IEFA)
Ishares Core S&p Small Cap Etf Etf (IJR)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Ishares Msci Eafe Value Etf Etf (EFV)

View all positions for Farther Finance Advisors

Top funds holding Lyell Immunopharma

BlackRock
Vanguard Group
Foresite Capital Management IV
WuXi AppTec
T. Rowe Price Associates
Alphabet
Geode Capital Management
Opaleye Management
Sc China Holding
FMR
Millennium Management
MIC Capital Management UK
Massachusetts Financial Services
Northern Trust
Charles Schwab Investment Management

View all funds holding Lyell Immunopharma